Latest Gilead Sciences Stories
Shareholder Resolutions filed by UAW Retiree Medical Benefits Trust DETROIT, March 12, 2015 /PRNewswire/ -- The U.S.
DALLAS, March 5, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "EpiCast Report Atrial Fibrillation - Epidemiology Forecast to 2023" report to its store.
EDISON, N.J., March 5, 2015 /PRNewswire/ -- ContraVir Pharmaceuticals, Inc.
CRANFIELD, England, February 26, 2015 /PRNewswire/ -- Now in its fifth year, the Productive Innovation Index (PII) celebrates the top 30 pharmaceutical companies most successful
PITTSBURGH and HYDERABAD, India, Feb. 23, 2015 /PRNewswire/ -- Mylan Inc.
RnRMarketResearch.com adds "Acute Heart Failure - Pipeline Review, H1 2015" report to its store.
When used in combination with a currently-available antiviral medication, a new experimental hepatitis C drug eradicated all signs of the disease within six weeks – the highest response and shortest duration ever achieved by any two-drug combination treatment.
LONDON, February 9, 2015 /PRNewswire/ -- London's status as a leading centre for the life sciences, financial and digital industries has attracted significant new investment
- Growing in low tufty patches.